Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05948475
Title Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma (FIRST-308)
Acronym FIRST-308
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors TransThera Sciences (Nanjing), Inc.
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | BEL | AUT

Additional content available in CKB BOOST